Oncotype DX

DIAGNOSTIC_TEST2 trials

Sponsors

British Columbia Cancer Agency, Gangnam Severance Hospital

Conditions

Breast Cancer

Unknown Phase

(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer

British Columbia Cancer AgencyBreast Cancer

Start: 2010-05-31Target: 80Updated: 2016-07-20

Endocrine Therapy Base on 21-gene RS

Not yet recruitingNCT07311122

Gangnam Severance HospitalBreast Cancer

Start: 2026-01-01End: 2028-12-31Target: 4000Updated: 2025-12-30